Kumar refers to GLP-1 prescriptions as one of the greatest medical breakthroughs of the decade. They have sparked a social phenomenon, too
In some countries, it has also received approval for chronic weight management in adults with obesity or overweight with weight-related comorbidities (marketed as Zepbound in some jurisdictions)
Taking a look at the outcomes for six patients which, yes, is a very small sample size who used semaglutide for weight loss, the team led by OSUs Kyle Simmons and OUs Jesse Richards found that all six experienced a significant reduction in symptoms
Tirzepatide can potentially reduce the effectiveness of oral contraceptives because it slows down the rate at which your stomach empties
SUSTAIN-6 (cardiovascular outcomes in T2D, Marso et al., NEJM 2016) reported a 26% reduction in MACE versus placebo over 104 weeks, the original cardiovascular signal that established the GLP-1 class's broader metabolic-protection profile beyond glycaemic control
Routes of Administration Subcutaneous (only practical route): Abdomen, love handles, or thighs